Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen lysinate vaginal solution after gynecological surgery
2018-001143-32Phase 4Completed
- Sponsor
- Intermed
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Ibuprofen L-lysine in postoperative pain, post-operative inflammation and Female genital tract disease, sponsored by Intermed. Primary endpoints: Pain reduction and Improvement of inflammation markers. Started Jun 2018; status: completed.
02
Drugs
Ibuprofen L-lysine
03
Conditions
postoperative painpost-operative inflammationFemale genital tract disease
Beyond the preview
Go deeper on 2018-001143-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001143-32.